Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

The characteristics of glaucoma patients in Cipto Mangunkusumo Hospital, 2001-2010

Poster Details

First Author: M.Faiqoh INDONESIA

Co Author(s):    W. Artini              

Abstract Details



Purpose:

To evaluate the characteristics of glaucoma patient and to compare the glaucoma proportion in numbers, blindness rate, severity as well as to know the underlying cause of secondary glaucoma in 10-year period.

Setting:

Department of Ophthalmology, Faculty of Medicine University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Methods:

A descriptive and retrospective study conducted in Cipto Mangunkusumo Hospital, Jakarta of glaucoma cases from January 2001 to December 2010.

Results:

This study collected 3.203 patients consist of male 1710 (53%) and female 1493 (47%). Mean age of the patient were older than 40 years (78,96%). Mean IOP were 28-29,5±15,5-16 mmHg, mean visual acuity (logMar) were 1,24±1,38 and 1,19±1,44 in the RE and LE recpectively. There were 619 (19,3%) patient with POAG, 600 (18,7%) patient with PACG and 1010 (31,5%) patient with secondary glaucoma. Mean age of POAG and PACG patient were 60-69 years and 50-59 years, respectively. The most common unilateral blindness is due to secondary glaucoma (31,5%), followed by PACG (18,1%) and POAG (13,7%). The most common bilateral blindess is due to secondary glaucoma (10,2%), followed by PACG (6,21%) and POAG (6,09%). Secondary glaucoma has the highest blindness rate (41,7 %). PACG is the second most common cause of blindess (24,2%) followed by POAG (19,8%). Secondary glaucoma related with lens is the most common caused followed by post surgery, trauma and inflammation.

Conclusions:

Majority of patients are male and older than 40 yo. The most common glaucoma diagnosis in 10-years period is secondary glaucoma, PACG and POAG respectively. FINANCIAL DISCLOSURE?: No

Back to previous

loading Please wait while information is loading.